Posts Tagged ‘Alejandro Forner’

Thursday April 12th, 2018

Hospital Clínic and IDIBAPS researchers participate in the new European clinical guidelines for the management of hepatocellular carcinoma

Two researchers from the Hepatic Oncology Unit at Hospital Clínic-IDIBAPS have participated in the development of the new clinical practice guidelines for the management of hepatocellular carcinoma developed by the European Association for the Study of the Liver (EASL). It is a consensus document that marks the road map in the diagnosis, treatment and monitoring of this type of cancer, which accounts for 90% of primary liver tumors. Read the rest of this entry »

Comments Closed
Monday March 19th, 2012

The Hepatic oncology team reviews for The Lancet the treatment of Hepatocellular carcinoma

Dr. Alejandro Forner i Dr. Jordi Bruix, primer i darrer signants del Seminar a The Lancet

Hepatocellular carcinoma is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. The team led by Dr. Jordi Bruix at Hospital Clínic of Barcelona – IDIBAPS is an international reference for the diagnostic and treatment of this disease. In fact, the classification that stratifies patients according to outcome and simultaneously links it with treatment indication is named after the Barcelona Clínic Liver Cancer (BCLC). The Lancet recently published a Seminar reviewing the latest trends in hepatocellular carcinoma management. The authors of the article are, from first to last, Dr. Alejandro Forner, Dr. Josep M. Llovet, and Dr. Jordi Bruix, all of them members of the Hepatic oncology team at IDIBAPS – Hospital Clínic.  Simultaneously, Dr. Jordi Bruix appeared as senior author in the recently published Saudi Guidelines for the Diagnosi and Management of Hepatocellular Carcinoma. This reinforces the international leadership of this team with direct participation in clinical practice consensus documents for Europe and the United States of America.

Read the rest of this entry »

Comments Closed